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Abstract
Purpose: Historically, the process of positioning a patient prior to imaging verifica-
tion used a set of permanent patient marks, or tattoos, placed subcutaneously. After
aligning to these tattoos, plan specific shifts are applied and the position is verified
with imaging, such as cone-beam computed tomography (CBCT). Due to a variety of
factors, these marks may deviate from the desired position or it may be hard to
align the patient to these marks. Surface-based imaging systems are an alternative
method of verifying initial positioning with the entire skin surface instead of tattoos.
The aim of this study was to retrospectively compare the CBCT-based 3D correc-
tions of patients initially positioned with tattoos against those positioned with the
C-RAD CatalystHD surface imager system.
Methods: A total of 6000 individual fractions (600–900 per site per method) were
randomly selected and the post-CBCT 3D corrections were calculated and recorded.
For both positioning methods, four common treatment site combinations were eval-
uated: pelvis/lower extremities, abdomen, chest/upper extremities, and breast. Sta-
tistical differences were evaluated using a paired sample Wilcoxon signed-rank test
with significance level of <0.01.
Results: The average magnitudes of the 3D shift vectors for tattoos were
0.9  0.4 cm, 1.0  0.5 cm, 0.9  0.6 cm and 1.4  0.7 cm for the pelvis/lower
extremities, abdomen, chest/upper extremities and breast, respectively. For the Cat-
alystHD, the average magnitude of the 3D shifts for the pelvis/lower extremities,
abdomen, chest/upper extremities and breast were 0.6  0.3 cm, 0.5  0.3 cm,
0.5  0.3 cm and 0.6  0.2 cm, respectively. Statistically significant differences
(P < 0.01) in the 3D shift vectors were found for all four sites.
Conclusion: This study shows that the overall 3D shift corrections for patients initially
aligned with the C-RAD CatalystHD were significantly smaller than those aligned with sub-
cutaneous tattoos. Surface imaging systems can be considered a viable option for initial
patient setup and may be preferable to permanent marks for specific clinics and patients.
P A C S
83.85.Ei, 87.55.Gh, 87.55.km, 87.55.Qr, 87.56.Da, 87.63.-d, 87.63.L-
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Received: 5 June 2017 | Revised: 20 July 2017 | Accepted: 27 July 2017
DOI: 10.1002/acm2.12183
58 | wileyonlinelibrary.com/journal/jacmp J Appl Clin Med Phys 2017; 18:6: 58–61
K E Y WORD S
C-RAD CatalystHD, patient setup, SGRT, subcutaneous tattoos, surface imaging
1 | INTRODUCTION
Historically, the process of positioning a patient prior to imaging ver-
ification used a set of permanent patient marks, or tattoos, placed
subcutaneously. These subcutaneous tattoos are traditionally placed
medially and on both lateral sides using a permanent ink injected at
a 30° angle perpendicular to the surface of the skin to a depth of 1–
2 mm.1,2 This configuration allows for a three point localization of
the initial isocenter. After aligning to these tattoos, plan specific
shifts are applied, and, often, the position is verified with x-ray volu-
metric imaging.3 Due to a variety of factors, including changes in
body habitus, localized radiation induced swelling/shrinking, and a
significant time difference between the placing of the marks and
treatment, these marks may deviate from the desired position or it
may be hard to align the patient to these marks.
Additionally, as overall patient survival continues to increase,
many patients are requesting not to have a permanent tattoo placed,
especially in pediatrics and breast cases.4,5 A publication from Crow
and Allen in 2010 detailed the psychosocial impacts of radiation tat-
tooing for breast cancer patients and specifically the long-lasting
effects and poorly documented psychological effects that can hap-
pen long after treatment.5 Of the women who were surveyed many
found “the tattoos as compounding the trials of dealing with signifi-
cant physical changes to their breasts and bodies arising from diag-
nosis and treatment.”5 The tattoos serve as a lasting and constant
reminder of cancer treatment long after treatments have finished.
While some patients may see these as necessary inconvenience, clin-
ical providers should be considerate of the patient experience, espe-
cially when an alternative method may have a reduced long term
psychological effect. Along with the psychological impact, an
increased prevalence of patients who have an allergy to many of the
specific inks used in subcutaneous marks has been reported.6,7 While
these situations may be comparatively rare, it is important to have a
reliable and accurate method of pre-positioning verification. With
the increasing use of nonionizing surface-based imaging systems, an
alternative method of verifying initial positioning exists that relies on
the entire skin surface instead of tattoos. The aim of this study was
to retrospectively compare the 3D corrections of patients positioned
with tattoos and with C-RAD CatalystHD.
2 | MATERIALS AND METHODS
2.A | C-RAD CatalystHD
The C-RAD CatalystHD (C-RAD, Uppsala, Sweden) is a ceiling-
mounted three camera nonionizing optical based imaging system cap-
able of monitoring patient setup and positioning, intra-fraction and
inter-fraction motion detection, and respiratory gating. The
CatalystHD has a scanning volume (X*Y*Z) of a 800 9 1300 9
700 mm with a scan speed of 220 complete 3D surfaces per second.
The cameras are mounted at fixed angles so that localization and visu-
alization of the patient are maintained for every gantry location by
projecting specific light patterns of a known wavelength (405 nm
(near-invisible violet), 528 nm (green) and 624 nm (red)) onto the
patients’ skin. The CatalystHD algorithm then matches the light pat-
tern that is projected onto the patients’ surface to a reference surface
acquired previously (either from the reference CT or from baseline
volume scan done prior to treatment). Based on the two acquired
images of the patient surface, the CatalystHD algorithm provides the
patient positioning errors and provides a correction of target position-
ing expressed in the six degrees of freedom.
2.B | Methods
Over a 24 month period, a total of 6000 individual fractions were ini-
tially aligned using either the CatalystHD or the traditional three point
subcutaneous marks. Between 600 and 900 individual fractions per site
per method were randomly selected and recorded for all patients and
fractions. For the three point subcutaneous mark positioning technique,
patients were aligned to the marked locations and the planned shifts
were implemented manually by the therapists. For the CatalystHD
positioning technique, patients were imaged, shifts were calculated,
and sent to the linear accelerator for automatic adjustment. For both
initial positioning methods, a kV-CBCT was acquired immediately fol-
lowing to adjust for any residual corrections. The anatomical goal for
these alignment corrections varied widely across all evaluated fractions
but were consistent within each patient regardless of initial setup tech-
nique. Four common treatment site combinations were evaluated for
both positioning methods: pelvis/lower extremities, abdomen, chest/
upper extremities, and breast. Statistical differences of the residual cor-
rections were evaluated using a paired sample Wilcoxon signed rank
test with significance level of <0.01. All evaluated patients had the abil-
ity to be initially positioned with either setup technique and the specific
choice of setup technique was at the discretion of the designated setup
therapist, which rotated weekly. All of the patients included in this data
analysis had setups from both techniques, to avoid potential bias from
patients that would have a clinical preference for only one setup tech-
nique. Additionally, therapists either setup with the traditional three
point subcutaneous marks or the surface imaging system, but not both.
3 | RESULTS
The average magnitudes of the post-CBCT 3D shift vectors and the
standard deviations for the traditional three point localization using
subcutaneous tattoos and localization using the surface imaging
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technique are listed in Table 1. Statistically significant differences
(P < 0.01) in the post-CBCT 3D shift vectors were found for all four
sites. Figures 1–4 show histograms of the magnitude of the 3D shift
vectors for both methods for all four site combinations.
4 | DISCUSSION
Historically, subcutaneous marks served as the primary (and often the
only) method of initial setup up for patients prior to verification.
Although, with the growth of the modern state-of-the-art image guid-
ance systems for use in Image Guided Radiation Therapy (IGRT),
including surface imaging systems, the dependence on and relevance
of these marks has been drastically reduced.8,9 With current standards
of care, where volumetric imaging is employed prior to treatment for
3D setup corrections, subcutaneous marks serve as a relic of the pre-
volumetric imaging standards or positioning. These permanent tattoos,
in the most basic sense, are “stationary” landmarks on an elastic body
organ whose elasticity is drastically changed during radiation ther-
apy.10 It is not uncommon for therapists to stretch and pull portions of
the skin with these marks to make marks properly align. This ability to
manually manipulate marks highlights the need for an alternative
method. For treatments like lung Stereotactic Body Radiation Therapy
(SBRT) and the treatment of breast cancer with deep inspiration
TAB L E 1 Summary of post-CBCT 3D corrections calculated
averages and standard deviations for a traditional three point
localization with subcutaneous tattoos and surface imaging
techniques.
Three point
localization Surface imaging
Average(cm) r(cm) Average(cm) r(cm)
Pelvis/lower extremities 0.9 0.4 0.6 0.3
Abdomen 1.0 0.5 0.5 0.3
Chest/upper extremities 0.9 0.6 0.5 0.3
Breast 1.4 0.7 0.6 0.2
0
20
40
60
80
100
120
Fr
eq
ue
nc
y
Magnitude of the 3D shi vectors (cm) 
Pelvis/lower Extremies
Three Point
Localizaon
Surface Imaging
F I G . 1 . Cumulative histograms showing the pre-CBCT 3D
corrections for a traditional three point localization and surface
imaging techniques for the pelvis/lower extremities.
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F I G . 2 . Cumulative histograms showing the pre-CBCT 3D
corrections for a traditional three point localization and surface
imaging techniques for the abdomen.
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F I G . 3 . Cumulative histograms showing the pre-CBCT 3D
corrections for a traditional three point localization and surface
imaging techniques for the chest/upper extremities.
0
20
40
60
80
100
120
140
Fr
eq
ue
nc
y
Magnitude of the 3D shi vectors (cm) 
Breast
Three Point
Localizaon
Surface
Imaging
F I G . 4 . Cumulative histograms showing the pre-CBCT 3D
corrections for a traditional three point localization and surface
imaging techniques for the breast.
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breath hold, where surface imaging technologies are already being uti-
lized, the question becomes are tattoos necessary?11 Clinically, regard-
less of the pre-imaging verification setup method, it is assumed that
patients are being positioned correctly due to the 3D volumetric imag-
ing. It is important and should be noted that this study is not advocat-
ing for a complete removal of subcutaneous tattoos in radiation
therapy but rather to evaluate an alternative solution for primary setup
that may be preferable for specific clinics and patients.
5 | CONCLUSION
This study shows that the overall 3D shift corrections for patients
initially aligned with the C-RAD CatalystHD were significantly smal-
ler than those aligned with subcutaneous tattoos. Surface imaging
systems should be considered a viable option for initial patient setup
and may be preferable to permanent marks for specific clinics and
patients.
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